Suppr超能文献

垂体多催化蛋白酶复合体胰凝乳蛋白酶样活性的抑制作用。

Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex.

作者信息

Vinitsky A, Michaud C, Powers J C, Orlowski M

机构信息

Department of Pharmacology, Mount Sinai School of Medicine, City University of New York, New York 10029.

出版信息

Biochemistry. 1992 Oct 6;31(39):9421-8. doi: 10.1021/bi00154a014.

Abstract

The multicatalytic proteinase complex (MPC), also referred to as proteasome, is a large molecular mass intracellular particle (approximately 700 kDa), which exhibits three distinct proteolytic activities designated as chymotrypsin-like, trypsin-like, and peptidylglutamyl-peptide hydrolyzing (PGPH), all sensitive to inhibition by 3,4-dichloroisocoumarin (DCI). The presence of a component resistant to inhibition by DCI with an apparent preference toward bonds on the carboxyl side of branched-chain amino acids has also been recently established. Peptide aldehydes and peptide alpha-keto esters containing a hydrophobic residue in the P1 position have been tested as potential inhibitors of the chymotrypsin-like activity. Three peptide aldehydes (benzyloxycarbonyl)-Leu-Leu-phenylalaninal (Z-LLF-CHO), N-acetyl-Leu-Leu-norleucinal (Ac-LLnL-CHO), and N-acetyl-Leu-Leu-methioninal (Ac-LLM-CHO) were found to be slow-binding reversible inhibitors with Ki values of 0.46, 5.7, and 33 microM, respectively. The simplest kinetic model for inhibition is consistent with a mechanism involving a slow and reversible association of the enzyme with the inhibitor to form a EI complex. The aldehyde inhibitors also inhibited the trypsin-like and PGPH activities of the complex albeit with much higher Ki values than those for chymotrypsin-like activity. Z-LLF-CHO, the most selective of the three aldehydes, did not inhibit the PGPH activity at concentrations of up to 200 microM and inhibited the trypsin-like activity with a Ki approximately 2 orders of magnitude higher than that for the chymotrypsin-like activity. The activity of the DCI-resistant component was not affected by Z-LLF-CHO.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

多催化蛋白酶复合体(MPC),也被称为蛋白酶体,是一种大分子质量的细胞内颗粒(约700 kDa),它具有三种不同的蛋白水解活性,分别被称为类胰凝乳蛋白酶活性、类胰蛋白酶活性和肽基谷氨酰肽水解(PGPH)活性,所有这些活性都对3,4-二氯异香豆素(DCI)的抑制敏感。最近还发现存在一种对DCI抑制有抗性的成分,它明显倾向于切割支链氨基酸羧基侧的肽键。含有P1位疏水残基的肽醛和肽α-酮酯已被测试作为类胰凝乳蛋白酶活性的潜在抑制剂。发现三种肽醛,即苄氧羰基-L-亮氨酰-L-亮氨酰苯丙醛(Z-LLF-CHO)、N-乙酰-L-亮氨酰-L-亮氨酰正亮氨酸醛(Ac-LLnL-CHO)和N-乙酰-L-亮氨酰-L-亮氨酰甲硫氨酸醛(Ac-LLM-CHO)是慢结合可逆抑制剂,其Ki值分别为0.46、5.7和33 μM。最简单的抑制动力学模型与一种机制相符,该机制涉及酶与抑制剂缓慢且可逆地结合形成EI复合物。醛类抑制剂也抑制了该复合体的类胰蛋白酶活性和PGPH活性,尽管其Ki值比类胰凝乳蛋白酶活性的Ki值高得多。三种醛中最具选择性的Z-LLF-CHO在浓度高达200 μM时不抑制PGPH活性,并且抑制类胰蛋白酶活性的Ki值比对类胰凝乳蛋白酶活性的Ki值高约2个数量级。对DCI有抗性的成分的活性不受Z-LLF-CHO的影响。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验